Floatz logo

SOLUBLE FLUORESCEIN

Metastatic Gastric Carcinoma

Mayo ClinicSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

48 Active assets in the Metastatic Gastric Carcinoma cohort.

Asset / SponsorPhaseRating
Irinotecan
City of Hope Medical Center
Phase 1/2CCC
Shr-A1811
Yunpeng Liu
Phase 2CCC
Dabrafenib
National Cancer Institute (NCI)
Phase 2CCC
Gdc-0449
National Cancer Institute (NCI)
Phase 2CCC
Relatlimab
National Cancer Institute (NCI)
Phase 2CCC

View all 50 →

Same molecule, other indications

SOLUBLE FLUORESCEIN is also rated in:

ovarian cancerDormant
CC
Indicative ·
43 / 100
View asset →
ovarian carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
primary peritoneal carcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →